Supreme Court Backs Lisa Cook, Defends Federal Reserve Independence Against Trump Firing Attempt 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge 
Iran Says It Closes Strait of Hormuz After Warning Shot at Vessel 
Trinidad Businessman Dominic Hadeed Appeals Detention Over Alleged Assassination Plot 
UK Sanctions 24 Russian-Linked Targets Over Cyberattacks and Election Interference 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
US Judge Seeks Explanation for DOJ’s Decision to Drop Gautam Adani Bribery Case 
Republican Senator Lindsey Graham Dies at 71, Leaving South Carolina Senate Seat Vacant 
Super Micro Employees Detained in Taiwan AI Server Export Investigation 
Judge Orders $5.8 Million Payment to E. Jean Carroll After Trump Loses Appeal Bid 
USA at 250: the Black American struggle for life, liberty and the pursuit of happiness 
Iran's Supreme Leader Vows Revenge as Trump Threatens Massive U.S. Military Response 
Reuters/Ipsos Poll: Most Americans Expect U.S.-Iran War to Be Prolonged 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election 
Brazil Court Bars Flavio Bolsonaro From Visiting Jair Bolsonaro Ahead of Election 
Two leading U.S. medical organizations have filed lawsuits against the Federal Trade Commission (FTC), alleging the agency launched unconstitutional investigations into their support of gender-affirming care for transgender youth. The American Academy of Pediatrics (AAP) and the Endocrine Society submitted separate complaints in federal court in Washington, D.C., challenging civil investigative demands issued by the FTC in January.
The lawsuits claim the FTC’s actions are politically motivated and tied to policies introduced under President Donald Trump’s administration. Both groups argue the agency is attempting to retaliate against them for endorsing gender-affirming medical treatment for minors experiencing gender dysphoria. They contend the document requests are overly broad, burdensome, and violate constitutional protections, including free speech rights.
According to court filings, the FTC issued a civil investigative demand to the AAP on January 15 as part of an inquiry into whether the organization made false or misleading claims related to pediatric gender dysphoria treatment. The Endocrine Society, which represents hormone specialists, received a similar request on January 20. A civil investigative demand functions similarly to a subpoena and is often used in consumer protection or antitrust investigations.
Gender dysphoria is a recognized medical condition involving distress due to a mismatch between a person’s gender identity and sex assigned at birth. The AAP has supported evidence-based gender-affirming care since releasing a 2018 policy statement backing appropriate medical interventions for transgender youth.
The FTC investigation comes nearly a year after President Trump signed executive orders recognizing only two sexes and directing federal agencies to end support or funding for gender-affirming care for minors. The AAP also noted that just days before receiving the FTC demand, a federal judge blocked the Department of Health and Human Services from terminating nearly $12 million in grants previously awarded to the organization.
In addition to challenging the FTC investigation, the AAP is pursuing separate legal action over changes to federal vaccine policy under Health Secretary Robert F. Kennedy Jr., arguing those revisions could reduce immunization rates and negatively impact public health.
